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Abstract
Objectives: To	assess,	retrospectively,	whether	older	age	has	an	impact	on	implant	
osseointegration	when	compared	with	younger	age.
Methods: All	patients	≥65	years	old	at	 implant	 installation,	 in	an	university	setting	
over	a	time‐period	of	11.5	years,	with	complete	anamnestic	data	and	follow‐up	until	
prosthetic	restoration	were	included,	and	any	early	implant	loss	(EIL;	i.e.	lack	of	os‐
seointegration	prior	to	or	at	the	time‐point	of	prosthetic	restoration)	was	recorded.	
Further,	one	implant,	from	each	of	the	elderly	patients,	was	attempted	matched	to	
one	implant	in	a	younger	patient	(35	to	<55	years	old	at	implant	installation)	from	the	
same	clinic	based	on	(a)	gender,	 (b)	 implant	region,	 (c)	smoking	status	and	(d)	bone	
grafting	 prior	 to/simultaneously	with	 implant	 installation.	 The	 potential	 impact	 of	
various	local	and	systemic	factors	on	EIL	in	the	entire	elderly	population,	and	in	the	
matched	elderly	and	younger	patient	group	was	statistically	assessed.
Results: Four	hundred	forty‐four	patients	≥65	years	old	(range	65.1–91.3;	56.8%	fe‐
male)	 receiving	1,517	 implants	were	 identified;	 10	patients	 had	one	EIL	 each	 (im‐
plant/patient	 level:	0.66/2.25%).	Splitting	 this	patient	cohort	additionally	 into	 four	
age	groups	[65–69.9	(n	=	213),	70–74.9	(n	=	111),	75–79.9	(n	=	80)	and	≥80	(n	=	40)],	
EIL	was	on	the	implant	level	0.41,	0.83,	0.34	and	2.26%,	respectively,	(p	=	.102)	and	
on	the	patient	 level	1.41,	2.70,	1.25	and	7.50%,	 respectively,	 (p	=	 .104);	multilevel	
analysis	showed	weak	evidence	of	association	of	increasing	age	with	higher	EIL	rate	
(p	=	.090).	Matching	was	possible	in	347	cases,	and	5	(1.44%)	and	9	(2.59%)	EIL	in	the	
elderly	and	younger	patients,	respectively,	were	observed	(p	=	.280).	EIL	could	not	be	
associated	with	any	systemic	condition	or	medication	intake.
Conclusions: Elderly	 patients	 ≥65	 years	 old	 presented	 a	 similarly	 low	 EIL	 rate	 as	
younger	patients	35	to	<55	years	old,	while	patients	≥80	years	old	may	have	a	slight	
tendency	for	a	higher	EIL	rate.	Hence,	ageing	does	not	seem	to	compromise	osseoin‐
tegration,	and	if	at	all,	then	only	slightly	and	at	a	later	stage	of	life.
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1  | INTRODUC TION
Current	data	indicate	that	about	20%	of	the	European	population	
is	≥65	years	old	and	about	6%	 is	≥80	years	old	 (Eurostat,	2018);	
the	prognosis	 is	 that	 these	percentages	will	 continue	 to	grow	 in	
the	 future.	 Taking	 this	 into	 account,	 together	with	 the	 fact	 that	
implant‐supported	 restorations	 significantly	 improve	 not	 only	
oral	 health‐related	 quality	 of	 life	 (Reissmann,	 Dard,	 Lamprecht,	
Struppek,	 &	Heydecke,	 2017),	 but	 also	 health‐related	 quality	 of	
life	(Naito	et	al.,	2006)	in	general,	elderly	patients	seeking	implant	
treatment	 are	 and	 will	 remain	 a	 significant	 part	 of	 daily	 clinical	
work	(Schimmel,	Müller,	Suter,	&	Buser,	2017).	In	a	recent	system‐
atic	 review	 of	 prospective	 trials	 on	 implant	 treatment	 in	 elderly	
patients	(i.e.	patients	being	≥65	years	old	at	the	time‐point	of	im‐
plant	 installation),	 implant	survival	rates	of	98%	and	91%	after	1	
and	10	years	of	loading,	respectively,	were	calculated	(Srinivasan,	
Meyer,	Mombelli,	&	Müller,	2017).	These	rates	are	similar	to	those	
previously	 reported	 for	 the	general	population;	 for	example,	 the	
survival	 rate	 of	 implants	 supporting	 single	 crowns	 is	 >97%	 and	
95%	after	5	and	10	years,	respectively,	and	that	of	implants	sup‐
porting	 fixed	 dental	 prostheses	 is	 >95%	 and	 93%,	 respectively	
(Hjalmarsson,	Gheisarifar,	&	Jemt,	2016;	Jung,	Zembic,	Pjetursson,	
Zwahlen,	 &	 Thoma,	 2012;	 Pjetursson,	 Thoma,	 Jung,	 Zwahlen,	 &	
Zembic,	2012).	Furthermore,	another	systematic	review	reported	
that	implant	loss	rates	of	older	patients	(i.e.	≥60	years	old)	did	not	
differ	significantly	from	those	of	younger	patients	(i.e.	≤54	years	
old)	(Sendyk	et	al.,	2017).
In	 this	 context,	 several	 factors	 associated	 with	 ageing	 may	
compromise	 implant	 osseointegration;	 for	 example,	 elderly	 pa‐
tients—compared	with	younger	patients—show	higher	rates	of	sys‐
temic	diseases	(e.g.	diabetes)	and	more	often	receive	medication/
treatment	(e.g.	bisphosphonates,	radiotherapy)	that	interfere	with	
wound	healing	in	general	and	bone	healing	in	particular	(Bartold,	
Ivanovski,	&	Darby,	2016;	Chambrone,	Mandia,	Shibli,	Romito,	&	
Abrahao,	2013).	Further,	ageing	per	se	influences	negatively	sev‐
eral	 stages	 of	 the	 implant	 integration	 process,	 in	 terms	 of	 both	
soft	and	hard	tissue	healing.	Briefly,	the	early	inflammatory	stage	
of	healing	is	delayed/prolonged	due	to	the	generally	increased	in‐
flammatory	response	 in	the	elderly	compared	to	younger	adults;	
similarly,	the	proliferative	phase	of	healing	 is	delayed/prolonged,	
among	 other	 factors,	 due	 to	 the	 reduced	 numbers	 of	 stem	 cells	
and	amount	of	growth	factors	in	the	elderly	(Bartold	et	al.,	2016).	
Nevertheless,	there	is	limited	information	on	early	implant	losses	
(EIL)	in	the	elderly,	that	is	implant	losses	prior	to	loading—an	ulti‐
mate	sign	of	compromised	osseointegration.	 Indeed,	 in	the	origi‐
nal	 studies	 included	 in	 the	 above‐mentioned	 systematic	 reviews	
(Sendyk	 et	 al.,	 2017;	 Srinivasan	 et	 al.,	 2017),	 information	 on	EIL	
was	often	missing,	while	 the	number	of	 elderly	patients	 in	most	
of	 the	original	 studies	was	general	 rather	small	 (i.e.	mostly	<50).	
Further,	in	studies	with	larger	elderly	patient	numbers	presenting	
rates	of	EIL	of	4.5%	to	9.7%	on	the	implant	and	patient	level,	re‐
spectively,	reporting	did	not	include	any	comparisons	to	younger	
patients	(Engfors,	Ortorp,	&	Jemt,	2004;	Kowar,	Eriksson,	&	Jemt,	
2013).	 Consequently,	 lack	 of	 significant	 differences	 between	 el‐
derly	 and	younger	patients,	 in	 terms	of	 survival	 rates	of	 already	
osseointegrated	 implants,	 as	 reported	 above,	 and	 lack	 of	 com‐
parative	data,	obviously	does	not	exclude	the	possibility	that	sig‐
nificant	differences	 in	terms	of	EIL	do	exist	between	elderly	and	
younger	patients,	but	simply	are	erroneously	not	captured.
Thus,	 information	 on	 EIL	 in	 the	 elderly	 is	 rather	 scarce	 in	 the	
currently	existing	literature.	Therefore,	the	aim	of	the	present	study	
was	to	assess,	retrospectively,	EIL	rate	in	a	large	elderly	patient	co‐
hort,	that	is	≥65	years	old	at	the	time‐point	of	implant	installation,	
and	compare	it	with	that	in	a	matched	younger	patient	cohort,	that	is	
35	to	<55	years	old	at	the	time‐point	of	implant	installation.
2  | MATERIAL S AND METHODS
The	present	retrospective	cohort	study	is	based	on	dental	records	
of	the	University	Clinic	of	Dentistry,	Medical	University	of	Vienna,	
Austria,	which	were	selected	automatically	(electronically)	based	on	
information	from	the	payment	system	of	the	clinic,	from	01/2005—
where	all	dental	records	became	digital—to	06/2016.	All	treatments	
were	 performed	 in	 the	 Division	 of	 Oral	 Surgery,	 by	 experienced	
oral	 surgeons,	 and	 the	 predominant	 implant	 types	 installed	 were	
NobelReplace	and	Replace	Select.	The	study	protocol	was	approved	
by	the	ethics	committee	of	the	Medical	University	of	Vienna	(EK‐Nr.	
Clinical Relevance
Scientific rationale for the study:	 Information	 on	 early	 im‐
plant	 loss	 (EIL;	 i.e.	 lack	of	osseointegration	prior	 to	or	 at	
the	 time‐point	 of	 prosthetic	 restoration)	 in	 the	 elderly	 is	
rather	scarce	in	the	currently	existing	literature.
Principal findings:	EIL	 in	patients	≥65	years	old	at	 implant	
installation	was	similarly	low	as	in	younger	patients	35	to	
<55	years	old	(1.44%	vs.	2.59%,	respectively),	matched	for	
gender,	 implant	 site,	 smoking	 and	bone	 grafting.	A	weak	
evidence	of	association	of	 increasing	age	with	higher	EIL	
rate	was	observed,	with	patients	≥80	years	old	showing	a	
rate	of	EIL	of	2.25%	and	7.5%	on	the	implant	and	patient	
level,	 respectively,	 compared	 with	 patients	 65–79	 years	
old	that	showed	rates	of	0.34%–0.83%	and	1.25%–1.70%,	
on	the	 implant	and	patient	 level,	 respectively;	yet,	 this	 is	
based	on	a	limited	number	of	EIL	cases	(i.e.	1–3)	in	the	vari‐
ous	age	subgroups.	EIL	could	not	be	associated	with	any	
systemic	condition	or	medication	 intake,	 in	this	relatively	
healthy	elderly	patient	cohort.
Practical implications:	Age	per	se	should	not	be	considered	
as	 a	 limiting	 factor	 for	 implant	 therapy,	 but	 it	 should	 be	
taken	into	account	that	patients	≥80	years	old	may	have	a	
slight	tendency	for	a	higher	risk	of	EIL	than	slightly	younger	
patients.
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1980/2016);	reporting	in	the	present	manuscript	complies	with	the	
STROBE	guidelines.
2.1 | Patient population
2.1.1 | Elderly patient cohort
The	dental	records	of	all	patients	who	had	paid/received	an	implant	
between	01/2005	and	06/2016	were	≥65	years	old	at	the	time‐point	
of	implant	installation,	were	extracted	and	manually	screened	twice	
by	two	examiners	(M.E.	and	M.K.)	for	complete	anamnestic	data	(i.e.	
records	on	systemic	diseases	and	medication	intake)	and	follow‐up	
until	prosthetic	restoration.	Patients	with	records	indicating	history	
of	head	and	neck	cancer	and/or	immune	deficiency	due	to	immuno‐
suppressant	medication	were	excluded.
The	 following	parameters	were	extracted:	 (a)	age,	 (b)	gender,	
(c)	implant	region,	(d)	EIL,	that	is	lack	of	osseointegration	prior	to	
placement	of	the	prosthesis	and	occlusal	loading	(yes/no;	primary	
outcome	 variable),	 (e)	 bone	 augmentation	 prior	 to	 or	 simultane‐
ously	with	 implant	 installation	 (yes/no),	 (f)	 smoking	status	at	 the	
time‐point	of	implant	installation	(yes/no),	(g)	history	of	periodon‐
titis,	 that	 is	 presence	 of	 bone	 loss	 judged	 on	 panoramic	 radio‐
graphs	or	if	the	patient	was	completely	edentulous	(yes/no;	please	
note	 that	 as	 standard	 at	 the	 University	 Clinic,	 all	 patients	were	
periodontally	healthy	or	periodontal	disease	was	treated	and	con‐
sidered	as	under	control	at	the	time‐point	of	implant	installation),	
(h)	presence	of	diabetes	mellitus,	osteoporosis	or	rheumatoid	ar‐
thritis	 (yes/no)	and	 (i)	 regular	 intake	of	bisphosphonates,	 statins,	
selective	 serotonin	 reuptake	 inhibitors	 (SSRI),	 proton‐pump	 in‐
hibitors	(PPI),	anticonvulsants,	corticosteroids,	antihypertensives,	
anticoagulants	or	non‐steroidal	anti‐inflammatory	drugs	 (NSAID)	
(yes/no).
2.1.2 | Younger patient cohort
Based	on	previous	studies	(Sendyk	et	al.,	2017),	which	applied	a	dif‐
ference	of	10	years	between	younger	and	older	patient	cohorts,	the	
“cut‐off	value”	for	the	younger	patients	was	defined	as	55	years	of	
age.	One	 implant	 in	 each	 elderly	 patient	was	 attempted	 to	match	
with	 an	 implant	 installed	 in	 a	 patient	 35	 to	 <55	 years	 old	 at	 the	
time‐point	 of	 implant	 installation,	 by	manually	 looking	 through	 an	
automatically	generated	list	of	dental	records	of	all	patients	who	had	
paid/received	an	 implant	at	 the	same	clinic	and	 timeframe,	on	 the	
basis	of	the	following	criteria:	(a)	gender,	(b)	implant	region	[i.e.	upper	
anterior	(tooth	no.	13–23)/upper	posterior/lower	anterior	(tooth	no.	
33–43)/lower	 posterior],	 (c)	 bone	 grafting	 prior	 to	 or	 simultane‐
ously	with	implant	installation	(yes/no)	and	(d)	smoking	status	(yes/
no).	Regarding	elderly	patients	with	≥2	implants,	the	implant	to	be	
matched	was	chosen	at	random;	if	matching	failed,	another	implant	
from	 the	 remaining	ones	 in	 the	 same	patient	was	again	 chosen	at	
random	and	matching	was	 attempted.	When	matching	 of	 one	 im‐
plant	in	a	given	patient	was	achieved,	then	the	next	patient	in	the	list	
was	attempted	to	match.	Similar	anamnestic	data	to	those	collected	
from	the	patients	in	the	elderly	patient	cohort	were	also	extracted	in	
this	younger	patient	group.
2.2 | EIL
From	each	EIL	case,	the	following	parameters	were	additionally	ex‐
tracted:	(a)	timing	of	implant	installation,	that	is	immediate/delayed,	
if	within	the	same	session	as	the	tooth	extraction	or	at	some	later	
time‐point,	respectively,	 (b)	 implant	dimension,	(c)	 implant	type,	(d)	
connection	type,	that	is	internal/external,	(e)	antibiotic	prescription	
at	the	time‐point	of	 implant	 installation	(yes/no),	 (f)	post‐operative	
healing	type,	that	is	submerged/non‐submerged	and	(g)	re‐implanta‐
tion	at	later	time‐point	(yes/no,	including	time‐point).
2.3 | Statistical analysis
Descriptive	 statistics	 were	 calculated	 for	 patient‐	 and	 implant‐re‐
lated	characteristics.	To	 identify	any	potential	differences/tenden‐
cies	 among	 the	 elderly	 and	 younger	 patients,	 both	 cohorts	 were	
sub‐classified	into	4	age	sub‐cohorts:	(a)	65–69.9/70–74.9/75–79.9/	
and	 ≥80	 years	 of	 age	 in	 the	 elderly	 group,	 and	 (b)	 35–39.9/40–
44.9/45–49.9/50–54.9	 years	 of	 age	 in	 the	 younger	 group.	 Fishers'	
exact	test	or	chi‐squared	test	was	used	to	assess	any	potential	dif‐
ferences:	(a)	between	patients	or	implants,	with	and	without	an	EIL,	
in	 the	elderly	patient	cohort,	 (b)	between	the	elderly	and	younger	
patient	 matched	 cohorts,	 and	 (c)	 among	 the	 4	 age	 sub‐cohorts,	
separately	for	the	elderly	and	younger	matched	patient	cohorts	re‐
garding	the	various	categorial	parameters	(i.e.	age	cohorts,	gender,	
implant	region,	EIL,	bone	augmentation,	smoking	status,	history	of	
periodontitis,	 presence/absence	of	 a	 systemic	 disease,	medication	
intake).	Patient‐specific	parameters	have	been	compared	on	the	pa‐
tient	 level,	while	 implant‐specific	parameters	on	 the	 implant	 level.	
Additionally,	 several	univariable	 random	effects	 logistic	 regression	
analyses	assessed	any	effect	of	the	various	predictors	(i.e.	age,	gen‐
der,	implant	region,	no.	of	implants	per	patient,	bone	augmentation,	
smoking	status,	history	of	periodontitis,	presence/absence	of	a	sys‐
temic	disease,	medication	intake)	on	the	primary	outcome	parameter	
(i.e.	EIL)	in	the	elderly	patient	cohort.	Parameters	significant	at	the	
a	=	0.20	were	considered	for	the	final	multivariable	model,	whereas	
age	 and	 gender	 were	 considered	 a	 priori	 confounders.	 Statistical	
analysis	 was	 performed	 using	 SPSS	 Version	 24.0	 (SPSS	 Inc.)	 and	
STATA	15.1	(StataCorp	LLC),	and	p‐values	<.05	were	considered	as	
statistically	significant.
3  | RESULTS
3.1 | Patient population
Out	of	628	patients	≥65	years	old	at	the	time‐point	of	implant	installa‐
tion,	444	patients	could	be	included	in	the	elderly	patient	cohort	herein	
(mean	age:	72.0	±	5.7;	range:	65–91	years;	56.8%	female);	most	com‐
mon	reasons	for	exclusion	were	no	follow‐up	after	implant	installation,	
that	is	prosthetic	restoration	was	performed	at	the	referring	dentist,	
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and	unclear	anamnestic	data.	This	elderly	patient	cohort	received	1,517	
implants	(range:	1–12	implants	per	patient).	Out	of	those	444	elderly	
patients,	347	could	be	matched	with	younger	patients	<55	years	old	
(elderly/younger	patient	cohort:	mean	age	71.0	±	5.0/46.5	±	6.0,	range	
65	to	89/35	to	<55	years,	respectively;	55.9%	female);	most	commonly,	
the	remaining	97	patients	could	not	be	matched	due	to	the	low	number	
of	lower	anterior	implants	in	younger	patients.	Data	on	implant	region,	
number	of	implants	per	patient,	bone	augmentation,	smoking	status,	
history	of	periodontitis,	presence	of	systemic	diseases	and	medication	
intake	are	presented	in	Table	1	for	the	elderly	patient	cohort	(n	=	444)	
and	in	Table	2	for	the	matched	patient	cohorts	(n	=	347	patients	each	in	
the	elderly	and	younger	patient	cohort).	The	elderly	patient	cohort	dif‐
fered	significantly	from	the	matched	younger	patient	cohort	in	several	
parameters	(p	<	.01;	Table	2);	that	is,	elderly	patients	presented	more	
often	with	a	history	of	periodontitis,	systemic	disease	(diabetes	mel‐
litus,	osteoporosis,	rheumatoid	arthritis)	and	regular	intake	of	several	
medications.
3.2 | EIL
In	 the	 elderly	 patient	 cohort,	 10	 patients	 had	 one	 EIL	 each,	 that	 is	
EIL	on	implant	and	patient	 level	was	0.66%	and	2.25%,	respectively.	
Specifically,	EIL	occurred	in	one	patient	each	with	2,	7,	and	8	implants,	
in	two	patients	each	with	3	and	5	implants,	and	in	three	patients	with	
6	implants.	EIL	rate	in	the	4	elderly	patient	sub‐cohorts	[i.e.	65–69.9	
(n	=	213),	70–74.9	(n	=	111),	75–79.9	(n	=	80)	and	≥80	years	old	(n	=	40),	
respectively]	was	0.41%,	0.83%,	0.34%	and	2.26%,	respectively,	on	the	
implant	level,	and	1.41%,	2.70%,	1.25%	and	7.50%,	respectively,	on	the	
patient	level;	the	difference	in	EIL	rate	between	the	≥80	years	sub‐co‐
hort	and	the	3	remaining	sub‐cohorts	was	not	statistically	significant	
(p = .102 and p	=	.104,	on	the	implant	and	patient	level,	respectively;	
Figure	1).	Similarly,	the	multivariable	random	effects	logistic	regression	
analysis	for	the	elderly	patient	cohort	indicated	only	weak	evidence	of	
association	of	higher	EIL	rate	with	increasing	age	(p	=	.090;	Appendix	
S1).	Further,	no	statistically	significant	differences	between	patients/
implants	with	and	without	EIL	and	no	significant	effects,	in	regard	to	
the	various	evaluated	parameters,	were	observed	within	 the	elderly	
patient	 cohort	 (Table	3	and	Appendix	S1).	 In	 regard	 to	 the	matched	
cohorts,	five	patients	in	the	elderly	group	versus	nine	patients	in	the	
younger	group	experienced	one	EIL	each,	that	is	1.44%	versus	2.59%,	
respectively	 (p	 =	 .280;	 Figure	 1).	 No	 statistically	 significant	 differ‐
ences	 were	 observed	 between	 patients/implants	 with	 and	 without	
EIL,	within	the	matched	elderly	and	younger	patient	cohorts	in	regard	
to	any	of	the	evaluated	parameters,	although	there	was	higher	preva‐
lence	of	diabetes	mellitus,	osteoporosis,	and	rheumatoid	arthritis	and	
regular	medication	 intake	 in	 the	elderly	patients	 compared	with	 the	
younger	ones	 (p	≥	 .174;	Table	4).	Further	details	on	all	EIL	cases	are	
listed	in	Table	5.
4  | DISCUSSION
The	results	of	the	present	study,	based	on	a	relatively	large	patient	
sample,	showed	that	EIL	are	not	more	frequent	in	elderly	(≥65	years	
old)	than	in	younger	patients	(<55	years	old),	and	in	general	are	sel‐
dom,	that	is	<1%	on	implant	and	around	2.5%	on	patient	level.	Thus,	
this	 finding	 appears	 to	 correspond	 well	 to	 the	 currently	 existing	
TA B L E  1  Characteristics	of	the	elderly	patient	cohort	(n	=	444)	
and	implant‐specific	details	(n	=	1,517)
Patient characteristics  
Age
Mean	±	SD	(min;	max) 72.0	±	5.7	(65;	91)
Cohorts	[65–69.9/70–74.9/75–
79.9/≥80	years	of	age;	n	(%)]
213/111/80/40
(48.0/25.0/18.0/9.0)
Gender	[female;	n	(%)] 252	(56.8)
Smoking	at	the	time‐point	of	implant	
installation	[n	(%)]
48	(10.8)
History	of	periodontitis	[yes;	n	(%)] 384	(86.5)
Systemic	disease	[present;	n	(%)]
Diabetes	mellitus 47	(10.6)
Osteoporosis 41	(9.2)
Rheumatoid	arthritis 20	(4.5)
Medication	intake	[yes;	n	(%)]
Bisphosphonates 31	(7.0)
Statins 94	(21.2)
Selective	serotonin	reuptake	inhibitors 48	(10.8)
Proton‐pump	inhibitors 66	(14.9)
Anticonvulsants 16	(3.6)
Corticosteroids 23	(5.2)
Antihypertensives 198	(44.6)
Anticoagulants 31	(7.0)
Non‐steroidal	anti‐inflammatory	drugs 116	(26.1)
Implant characteristics
Implants	per	patient	[n	(%)]
1 61	(13.7)
2 115	(25.9)
3 30	(6.8)
4 170	(38.3)
5 17	(3.8)
6 24	(5.4)
7 9	(2.0)
8 5	(1.1)
9 4	(0.9)
10 7	(1.6)
11 1	(0.2)
12 1	(0.2)
Implant	region	[n	(%)]
Upper	posterior/anterior 353	(23.3)/141	(9.3)
Lower	posterior/anterior 573	(37.8)/450	(29.7)
Bone	augmentation	[yes;	n	(%)] 228	(15.0)
Abbreviation:	SD,	standard	deviation.
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knowledge	on	implant	therapy	in	the	elderly.	As	mentioned	earlier,	
in	a	recent	systematic	review	on	 implants	 in	patients	≥65	years	of	
age,	post‐loading	 implant	survival	 rates	of	98%	at	1	year	and	91%	
at	10	years	were	calculated	(Srinivasan	et	al.,	2017).	Similarly,	in	an‐
other	 systematic	 review	on	 implant	 losses	 in	older	 (≥60	years	old)	
versus	younger	 (≤54	years	old)	patients,	no	 significant	differences	
were	observed	between	the	two	groups	in	terms	of	implant	survival	
(94%	vs.	95%,	respectively,	based	on	four	studies	included)	(Sendyk	
et	al.,	2017).	However,	the	high	survival	rates	reported	in	these	re‐
views	 regarded	mainly	osseointegrated	 implants	and	EIL	were	not	
specifically	 addressed;	 in	 most	 of	 the	 original	 studies	 included	 in	
these	reviews,	information	on	EIL	was	often	missing,	while	the	num‐
ber	of	elderly	patients	was	in	general	rather	small	(i.e.	mostly	<50).	
Therefore,	 possible	 significant	 differences	 between	 elderly	 and	
younger	patients	in	terms	of	EIL	might	have	been	overseen.
Older	age	per	se	 is	shown	to	negatively	 influence	wound	heal‐
ing	on	several	 levels.	Osseointegration	follows	the	regular	steps	of	
osseous	wound	 healing,	 starting	with	 an	 inflammatory	 phase	 due	
to	 the	 surgical	 trauma	of	 implant	 installation	 and	 is	 followed	by	 a	
proliferative	stage,	where	new	tissue	is	formed.	Older	age	is	shown	
to	influence	the	cells	and	mediators	involved	in	these	processes;	el‐
derly	patients	are	producing	larger	amounts	of	inflammatory	media‐
tors	and	thereby	show	an	increased/stronger	inflammatory	reaction,	
and	 consequently,	 a	 prolonged	 inflammatory	phase	 is	 observed	 in	
the	 elderly	 compared	with	 younger	 patients.	 Further,	 the	 number	
and	function	of	stem	cells,	 including	growth	factor	production,	are	
decreased	with	increasing	age,	resulting	in	reduced	new	bone	tissue	
formation	 capacity	 and	 imbalanced	 remodelling,	which	 in	 turn	 af‐
fects	 tissue	maturation	 (Bartold	et	 al.,	2016;	Bosshardt,	Chappuis,	
&	Buser,	2017;	Chan	&	Duque,	2002;	Gibon,	Lu,	&	Goodman,	2016).	
 
Young patient cohort 
(<55 years of age)
Elderly patient cohort 
(≥65 years of age)
Age
Mean	±	SD	(min;	max)a 46.5	±	6.0	(35;	55) 71.0	±	5.0	(65;	89)
Cohortsb	[n	(%)] 56/75/92/124
(16.1/21.6/26.5/35.8)
171/104/49/23
(49.3/30.0/14.1/6.6)
History	of	periodontitis	[yes;	n	(%)]a 114	(32.9) 314	(90.5)
Systemic	disease	[yes;	n	(%)]
Diabetes	mellitusa 3	(0.9) 37	(10.7)
Osteoporosisa 1	(0.3) 28	(8.1)
Rheumatoid	arthritisa 1	(0.3) 18	(5.2)
Medication	intake	[yes;	n	(%)]
Bisphosphonatesa 1	(0.3) 23	(6.6)
Statinsa 9	(2.6) 71	(20.5)
Selective	serotonin	reuptake	
inhibitorsa
11	(3.2) 38	(11.0)
Proton‐pump	inhibitorsa 8	(2.3) 44	(12.7)
Anticonvulsants 3	(0.9) 11	(3.2)
Corticosteroids 10	(2.9) 21	(6.1)
Antihypertensivesa 36	(10.4) 152	(43.8)
Anticoagulantsa 2	(0.6) 27	(7.8)
Non‐steroidal	anti‐inflammatory	
drugsa
9	(2.6) 85	(24.5)
 Matching criteria
Gender	[female;	n	(%)] 194	(55.9)  
Smoking	at	the	time‐point	of	im‐
plant	installation	[n	(%)]
44	(12.7)  
Implant	region	[n	(%)]
Upper	posterior/anterior 94	(27.1)/24	(6.9)  
Lower	posterior/anterior 200	(57.6)/29	(8.4)  
Bone	augmentation	[yes;	n	(%)] 65	(18.7)  
Abbreviation:	SD,	standard	deviation.
aInter‐group	comparison	(presented	a	statistically	significant	difference	(p	<	.01).	
bYoung	patient	cohort:	35–39.9/40–44.9/45–49.9/50–54.9	years	of	age;	elderly	patient	cohort:	
65–69.9/70–74.9/75–79.9/>80	years	of	age.	
TA B L E  2  Characteristics	of	the	
matched	patient	cohorts	(n	=	347	patients	
each	in	the	young	and	elderly	patient	
cohort;	each	patient	contributed	with	one	
implant)
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F I G U R E  1  EIL	rate	(%)	on	the	patient	
(light	blue)	and	implant	(dark	blue)	level	
in	the	elderly	patient	cohort	(n	=	444),	
divided	into	4	sub‐cohorts.	The	matched	
population	(young	patient	cohort	is	
displayed	in	light	purple,	elderly	patient	
cohort	in	dark	purple)	consisted	of	347	
patients	contributing	with	one	implant	
each.	The	numbers	on	top	of	the	bars	
present	the	actual	numbers	of	EIL	
out	of	the	total	numbers	of	patients/
implants,	and	the	white	numbers	inside	
the	bars	represent	the	relative	risk	for	
EIL	compared	to	the	sub‐cohort	of	
patients	≥80	years	of	age	or	compared	
to	the	matched	elderly	patient	cohort,	
respectively
Patient characteristics
EIL
p‐valueNo (n = 434) Yes (n = 10)
Age	cohorts	(65–69.9/70–74.9/75–
79.9/≥80	years	of	age;	n)
210/108/79/37 3/3/1/3 .104
Gender	(female/male;	n) 249/185 3/7 .109
Smoking	status	at	the	time‐point	of	implant	
installation	(non‐smoker/smoker;	n)
383/48 9/1 1.000
History	of	periodontitis	(no/yes;	n) 60/374 0/10 .371
Systemic	disease	(no/yes;	n)
Diabetes	mellitus 388/46 9/1 1.000
Osteoporosis 393/41 10/0 .609
Rheumatoid	arthritis 414/20 10/0 1.000
Medication	intake	(no/yes;	n)
Bisphosphonates 403/31 10/0 1.000
Statins 342/92 8/2 1.000
Selective	serotonin	reuptake	inhibitors 386/48 10/0 .610
Proton‐pump	inhibitors 369/65 9/1 1.000
Anticonvulsants 418/16 10/0 1.000
Corticosteroids 411/23 10/0 1.000
Antihypertensives 240/194 6/4 1.000
Anticoagulants 403/31 10/0 1.000
Non‐steroidal	anti‐inflammatory	drugs 318/116 10/0 .070
Implant characteristics No (n = 1,507) Yes (n = 10) p‐value
Implant	region	(upper	posterior/upper	ante‐
rior/lower	posterior/lower	anterior;	n)
350/140/571/446 3/1/2/4 .704
Bone	augmentation	(no/yes;	n) 1,280/227 9/1 1.000
Abbreviation:	EIL,	early	implant	loss.
TA B L E  3  Frequency	distribution	of	
the	various	patient‐	and	implant‐related	
parameters	in	EIL	and	non‐EIL	cases,	
within	the	elderly	patient	cohort	(i.e.	444	
patients	with	1,517	implants)
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Indeed,	 it	 has	 been	 demonstrated	 in	 preclinical	 trials	 that	 osse‐
ointegration	can	be	compromised	in	older	age	(Shirota	et	al.,	1993;	
Takeshita,	Murai,	 Ayukawa,	 &	 Suetsugu,	 1997).	 For	 example,	 tita‐
nium	implants	placed	in	the	tibia	of	old	rats	(1.5	years	old)	showed	
only	 about	 1.5%	 bone‐to‐implant‐contact	 (BIC)	 after	 4	 weeks	 of	
healing,	compared	with	40%	and	29%	BIC	in	young	(1.5	months	old)	
and	adult	(5.5	months	old)	rats,	respectively	(Takeshita	et	al.,	1997).	
Furthermore,	older	age	is	associated	with	high	rates	of	systemic	dis‐
eases	and	elderly	patients	receive	more	often	medications	that	 in‐
terfere	with	wound	healing	in	general	and	bone	healing	in	particular	
(Bartold	et	al.,	2016).	Thus,	the	possibility	of	different	EIL	rates	in	the	
elderly	and	in	younger	patients	appeared	as	a	reasonable	concern.
In	this	context,	a	variety	of	factors	have	been	associated	with	an	
increased	EIL	rate;	examples	are—but	not	limited	to—smoking,	max‐
illary	 site,	 male	 gender,	 short	 implant	 length,	 implant	 type/brand,	
number	of	 implants,	 immediate	placement,	 need	of	bone	grafting,	
non‐submerged	 healing,	 history	 of	 periodontitis,	 the	 clinician	 and	
specific	 medication	 intake	 (Alsaadi,	 Quirynen,	 Komárek,	 &	 van	
Steenberghe,	2007;	Antoun,	Karouni,	Abitbol,	Zouiten,	&	Jemt,	2017;	
Berglundh,	Persson,	&	Klinge,	2002;	Bryant,	1998;	Chrcanovic,	Kisch,	
Albrektsson,	 &	 Wennerberg,	 2016;	 Derks	 et	 al.,	 2015;	 Esposito,	
Grusovin,	 Loli,	 Coulthard,	 &	 Worthington,	 2010;	 Hickin,	 Shariff,	
Jennette,	 Finkelstein,	 &	 Papapanou,	 2017;	 Jemt,	 2017;	 Manzano	
et	al.,	2016;	Olate,	Lyrio,	de	Moraes,	Mazzonetto,	&	Moreira,	2010;	
Olmedo‐Gaya,	Manzano‐Moreno,	Cañaveral‐Cavero,	Dios	Luna‐del	
Castillo,	 &	 Vallecillo‐Capilla,	 2016;	 Palma‐Carrió,	 Maestre‐Ferrín,	
Peñarrocha‐Oltra,	 Peñarrocha‐Diago,	 &	 Peñarrocha‐Diago,	 2011;	
Pommer	 et	 al.,	 2011;	 Troiano	 et	 al.,	 2018).	 For	 example,	 PPI	 (Al	
Subaie	et	al.,	2016;	Chrcanovic,	Kisch,	Albrektsson,	&	Wennerberg,	
2017;	Wu	et	al.,	2017),	SSRI	 (Wu	et	al.,	2014)	and	antidepressants	
in	general	(Chrcanovic	et	al.	2016),	which	are	all	rather	common	in	
the	elderly,	have	been	associated	with	an	increased	risk	for	implant	
failure.	The	matching	procedure	herein	accounted	for	four	factors,	
that	 is	 smoking,	 gender,	 jaw	 site	 and	need	of	bone	grafting,	while	
some	other	factors	did	not	vary	or	were	controlled	through	the	rou‐
tines	of	the	university	clinic,	that	is	mainly	the	same	type	of	implant	
(i.e.	NobelReplace/Replace	Select)	was	installed	by	experienced	oral	
surgeons;	all	periodontitis	patients	were	considered	generally	suc‐
cessfully	treated	prior	to	implant	 installation,	and	diabetic	patients	
were	generally	well	controlled.	Within	this	context,	the	absence	of	
data	 on	 the	 reason	of	 tooth	 loss	 for	 each	 single	 tooth	 cannot	 ex‐
clude	the	possibility	that	some/several	of	the	teeth	were	lost	due	to	
TA B L E  4  Frequency	distribution	of	the	various	patient‐	and	implant‐related	parameters	in	EIL	and	non‐EIL	cases,	in	the	matched	patient	
cohorts
Patient and implant characteristics
Elderly patient cohort 
(≥65 years of age)  
Early implant loss
p‐value
Younger patient cohort 
(<55 years of age)  
Early implant loss
p‐valueNo (n = 342) Yes (n = 5) No (n = 338) Yes (n = 9)
Age	cohortsa	(n) 168/103/49/22 3/1/0/1 .499 54/72/92/120 2/3/0/4 .328
Gender	(female/male;	n) 193/149 1/4 .174 189/149 5/4 1.000
Smoking	status	at	the	time‐point	of	implant	instal‐
lation	(non‐smoker/smoker;	n)
299/43 4/1 .494 296/42 7/2 .319
History	of	periodontitis	(no/yes;	n) 33/309 0/5 1.000 229/109 4/5 .161
Systemic	disease	(no/yes;	n)
Diabetes	mellitus 305/37 5/0 1.000 335/3 9/0 1.000
Osteoporosis 314/28 5/0 1.000 337/1 9/0 1.000
Rheumatoid	arthritis 324/18 5/0 1.000 337/1 9/0 1.000
Medication	intake	(no/yes;	n)
Bisphosphonates 319/23 5/0 1.000 337/1 9/0 1.000
Statins 271/71 5/0 .588 329/9 9/0 1.000
Selective	serotonin	reuptake	inhibitors 304/38 5/0 1.000 327/11 9/0 1.000
Proton‐pump	inhibitors 298/44 5/0 1.000 330/8 9/0 1.000
Anticonvulsants 331/11 5/0 1.000 335/3 9/0 1.000
Corticosteroids 321/21 5/0 1.000 328/10 9/0 1.000
Antihypertensives 191/151 4/1 .391 303/35 8/1 1.000
Anticoagulants 315/27 5/0 1.000 336/2 9/0 1.000
Non‐steroidal	anti‐inflammatory	drugs 257/85 5/0 .340 330/8 8/1 .213
Implant	region	(upper	posterior/upper	anterior/
lower	posterior/lower	anterior;	n)
92/23/199/28 2/1/1/1 .303 93/23/194/28 1/1/6/1 .724
Bone	augmentation	(no/yes;	n) 277/65 5/0 .588 274/64 8/1 1.000
aElderly	patient	cohort:	65–69.9/70–74.9/75–79.9/>80	years	of	age;	Younger	patient	cohort:	35–39.9/40–44.9/45–49.9/50–54.9	years	of	age.	
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other	reasons	than	periodontitis.	However,	due	to	the	 lack	of	spe‐
cific	data	for	all	patients	and	based	on	the	high	prevalence	of	mod‐
erate	or	severe	periodontitis	 in	populations	above	65	years	of	age	
(e.g.	92%	in	Germany;	Holtfreter,	Kocher,	Hoffmann,	Desvarieux,	&	
Micheelis,	2010),	it	seemed	reasonable	to	assume	that	all	completely	
edentulous	 patients	 suffered	 from	 some	 degree	 of	 periodontitis.	
Nevertheless,	other	 factors	 largely	 inherent	with	ageing	could	not	
be	controlled	 (matched	to),	but	were	accounted	for;	 indeed,	 in	the	
present	study	population,	the	elderly	patient	cohort	presented	a	sig‐
nificantly	higher	frequency	of	medication	intake	(bisphosphonates,	
statins,	SSRI,	PPI,	antihypertensives,	anticoagulants	and	NSAID)	as	
well	as	higher	prevalence	of	osteoporosis	and	rheumatoid	arthritis,	
compared	with	the	matched	younger	patient	cohort.	In	the	younger	
population,	 none	 of	 the	 investigated	 systemic	 diseases	 appeared	
in	>1%	and	none	of	the	medications	was	taken	by	more	than	3.5%	
of	the	patients,	except	of	antihypertensives	(10%);	so,	the	younger	
population,	 herein,	 should	 be	 considered	 as	 relatively	 healthy.	No	
association	of	any	of	those	parameters	with	EIL	was	observed	in	the	
present	study,	neither	in	the	elderly	nor	in	the	younger	patient	group.	
Indeed,	in	both	groups,	a	very	low	number	of	EIL	were	observed	and	
in	most	cases	of	EIL,	the	various	evaluated	parameters	(e.g.	systemic	
disease,	medication	intake	and	bone	augmentation)	were	not	pres‐
ent.	The	rationale	to	use	2	cohorts	with	a	minimum	of	10	years	of	
age	difference,	herein,	was	based	on	the	assumption	that	if	age	had	
an	effect,	this	would	be	easier	to	observe	when	using	2	distinct	age	
groups.	The	rationale	to	select	only	one	implant	to	represent	each	
individual	in	the	old	versus	younger	group	was	to	have	balance	in	the	
groups	 for	4	conceptually	 relevant	parameters	 (i.e.	gender,	 region,	
smoking,	augmentation).	Further,	the	extent	of	therapy	(i.e.	number	
of	 implants	 installed)	was	 not	 considered	 during	matching	 herein,	
because	it	was	anticipated	that	a	large	number	of	patients	would	not	
be	able	to	match,	due	to	the	fact	that	younger	patients	would	most	
likely	bear	 a	 lower	number	of	 implants	 compared	with	 the	elderly	
ones.	In	this	context,	no	effect	of	the	number	of	implants	per	patient	
on	EIL	was	observed	in	the	elderly	patient	cohort.	In	perspective,	a	
different	valid	approach	to	address	the	topic	could	have	been	using	
an	unmatched	sample	and	performing	a	simple	regression	analysis	
with	age	as	 the	 independent	 factor	and	correcting	 for	 the	various	
parameters,	or	perform	hierarchical	analyses	 including	all	 implants	
of	a	patient.
In	 this	 context,	 the	 elderly	 patients	 herein	 cannot	 be	 consid‐
ered	 as	 a	 severely	 multi‐medicated	 and/or	 multimorbid	 population.	
Specifically,	only	three	types	of	medication	have	been	taken	by	more	
than	20%	(i.e.	statins,	antihypertensives	and	NSAID),	while	two	medi‐
cations	were	taken	by	10%–20%	of	the	elderly	population	(i.e.	SSRI	and	
PPI).	Further,	only	11%	presented	with	diabetes	mellitus	and	only	9%	
with	osteoporosis	that	were	also	receiving	treatment.	It	may	indeed	be	
that	elderly	patients	seeking	implant	therapy	are	in	generally	relatively	
healthier	 than	 the	 average	 elderly	 population;	 a	 similar	 observation	
has	been	made	in	previous	reports	on	implant	therapy	in	the	elderly	
(Compton	et	al.,	2017;	Kowar,	Stenport,	&	Jemt,	2014).	This	may	also	
partly	explain	the	observation	that	the	matched	younger	patient	co‐
hort	herein	presented	an	EIL	rate	almost	2	times	higher	than	that	in	the	
elderly	patients.	Another	possibility	may	be	that	elderly	patients	are	
more	likely	afraid	of	complications	(Ellis	et	al.,	2011;	Müller	et	al.,	2013)	
and,	therefore,	 follow	more	carefully	the	post‐operative	 instructions	
(e.g.	avoiding	wearing	a	removable	prosthesis	shortly	after	the	opera‐
tion).	In	general,	control	of	all	confounders	is	difficult	to	achieve	in	large	
patient	cohorts	and	establishment	of	an	 implant	register,	as	recently	
suggested	(Klinge	et	al.,	2018),	may	hopefully	support	a	more	complete	
risk	factor	analysis	in	the	future.
Sixty‐five	years	of	age	has	been	used	as	the	cut‐off	to	define	el‐
derly	in	several	studies,	including	the	systematic	review	of	Srinivasan	
et	al.	2017;	still,	one	may	argue	that	lack	of	significant	differences	be‐
tween	the	elderly	and	younger	patients	reported	previously	and	ob‐
served	herein	is	because	this	cut‐off	age	is	simply	too	low.	Indeed,	the	
multilevel	analysis	for	the	elderly	patient	cohort	indicated	only	weak	
evidence	of	association	of	increasing	age	with	higher	EIL	rate;	in	the	40	
patients	≥80	years	old	contributing	with	136	implants	herein,	EIL	was	
2.3%	on	the	implant	and	7.5%	on	the	patient	level,	compared	with	pa‐
tients	65–79	years	old	that	showed	rates	of	0.34%–0.83%	and	1.25%–
1.70%,	on	the	implant	and	patient	level,	respectively.	Nevertheless,	it	
should	not	be	forgotten	that	these	percentages	still	represent	a	limited	
number	of	EIL	cases	(i.e.	1–3	per	sub‐cohort).	In	previous	studies	with	
relatively	large	numbers	of	patients	≥80	years	of	age,	where	EIL	was	
reported,	more	or	 less	similar	 failure	rates	as	 those	observed	herein	
were	recorded	(Engfors	et	al.,	2004;	Kowar	et	al.	2013).	Specifically,	in	
a	retrospective	evaluation	of	133	patients	with	761	implants,	EIL	was	
4.5%	on	the	implant	level	(Engfors	et	al.,	2004),	while	in	another	anal‐
ysis	of	72	patients	with	265	implants,	seven	patients	had	1	EIL	each	
(i.e.	9.7%	on	the	patient	level)	(Kowar	et	al.,	2013).	Still,	92.5%	of	the	
patients	≥80	years	old	in	the	present	study	showed	successful	primary	
osseointegration	and	received	the	prosthetic	restoration.
Considering	 the	 facts/limitations	 that	 the	 present	 study	 is	 of	
retrospective	 character,	 both	 elderly	 and	 younger	 patient	 groups	
were	 relatively	 healthy,	 the	 operators	 were	 experienced	 oral	 sur‐
geons,	and	only	 few	EIL	were	observed,	 it	 is	nevertheless	 reason‐
able	to	conclude,	that	based	on	a	relatively	large	number	of	elderly	
patients—when	compared	with	patient	numbers	in	previously	pub‐
lished	studies—ageing	does	not	seem	to	compromise	osseointegra‐
tion,	and	if	at	all,	then	only	slightly	and	at	a	later	stage	of	life.
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